GlyNAC supplementation in OA significantly lowered muscle p16 INK4 and inflammatory cytokines representative of SASP, suggesting a senolytic effect
Choose tesamorelin when the goal is documented visceral-fat reduction, when there is metabolic context (HIV lipodystrophy, NAFLD, central adiposity with insulin resistance), when the patient can commit to daily injections for 6-12 months, and when IGF-1 monitoring infrastructure exists
These ingredients help convert fat into energy, support metabolism, and promote liver health all important factors to achieve weight loss
GLP-1s are considered to be safe and effective when used as indicated
The doctor will evaluate factors such as overall health, diabetes management, and weight loss goals before prescribing a GLP-1 receptor agonist